In a now-deleted comment, "selimthegrim" posted, "Yes, let's talk more about their vaccine with 50% efficacy pre-Delta. Do you see other countries clamoring for it?" "saberience" followed up with, "The Chinese vaccine is totally shit though in terms of efficacy compared to other vaccines, and in fact, where I live the Chinese vaccines aren't accepted any longer if you need to travel etc."

Do you mean Sinovac CoronaVac, CanSino Convidecia, Minhai, the Chinese Academy of Medical Sciences vaccine, Medigen, Zifivax, or one of the three Sinopharm vaccines? Because actually China developed nine vaccines, not one.

One of them is in fact the one other countries clamor for most: https://en.wikipedia.org/wiki/CoronaVac says, "A real-world study of tens of millions of Chileans who received CoronaVac found it 66% effective against symptomatic COVID-19, 88% against hospitalization, 90% against ICU admissions, and 86% against deaths. ... As of July 2021, CoronaVac was the most widely used COVID-19 vaccine in the world, with 943 million doses delivered. As of 14 October 2021, CoronaVac is the COVID-19 vaccine with most doses administered worldwide." https://en.wikipedia.org/wiki/CoronaVac#Authorizations shows that it's approved almost everywhere in the world except the Five Eyes countries, Russia, and the EU.

But I was talking about CanSino Convidecia, the single-dose vaccine they wanted to give me here in the hospital until they heard I was probably going to need to travel to the US. https://en.wikipedia.org/wiki/Convidecia says, "In February 2021, global data from Phase III trials and 101 COVID cases showed that the vaccine had a 65.7% efficacy in preventing moderate symptoms of COVID-19, and 91% efficacy in preventing severe disease. ... According to the Chinese state media, the team registered an experimental COVID-19 vaccine for Phase I trial in China on 17 March 2020 to test its safety. The trial was conducted on 108 healthy adults aged 18 to 60 in two medical facilities in Wuhan, Hubei province. ... In April, Ad5-nCoV became the first COVID-19 vaccine candidate in the world to begin Phase II trials. ... On 25 June 2020, China approved the vaccine for limited use by the military."

https://en.wikipedia.org/wiki/History_of_COVID-19_vaccine_de... explains in more detail, "On 24 June 2020, China approved the CanSino vaccine for limited use in the military, and two inactivated virus vaccines for emergency use in high-risk occupations." It cites https://www.scmp.com/news/china/society/article/3103121/coro..., which explains that by September --- two months before any vaccines were approved in most other countries --- 350,000 people had already been vaccinated in China.

Convidecia isn't approved in nearly as many countries as CoronaVac and the Sinopharm BIBP vaccine, but the particular achievement I wanted to point out here was being able to get vaccines (three different vaccines) deployed to people who needed them in the field, six months after the pandemic was discovered and six months before any other country in the world. And, contrary to your claims, it turned out to be a lot more than 50% effective.

So, in this case as well as in many others, "It's also not clear that China is particularly good at leading high tech innovation. If you just look at the dollars and cents, they should be inventing new technology at a similar rate as the US. Doesn't seem like they're pulling their weight," is the opposite extreme from the truth, to an astounding degree.